Market Cap (In USD)
139.81 Million
Revenue (In USD)
3.04 Million
Net Income (In USD)
-35.97 Million
Avg. Volume
119.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.3204-0.54385
- PE
- -
- EPS
- -
- Beta Value
- 1.342
- ISIN
- AU0000095416
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Andreas Fouras M.A.I.C.D., Ph.D.
- Employee Count
- -
- Website
- https://www.4dmedical.com
- Ipo Date
- 2021-02-02
- Details
- 4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
More Stocks
-
6674
-
BMHSPT Bundamedik Tbk
BMHS
-
BSE
-
COF-PJ
-
3913GreenBee, Inc.
3913
-
ENELAMEnel Américas S.A.
ENELAM
-
5215
-
0083